Otoneurological and neurological consequences of acute infectious ENT diseases
https://doi.org/10.51793/OS.2022.25.12.013
Abstract
Acute respiratory infections often cause temporary disability. According to the World Health Organization, adults experience acute respiratory infections approximately twice a year. The course of acute respiratory viral infections is often accompanied by the development of complications. The second most common complication of acute respiratory viral infection is acute otitis media. It is believed that by the age of three, acute otitis media is transferred once by at least 71% of children, by 7 years of age – 95%. Currently, the clinical picture of acute otitis media has been studied in detail, which allows us to speak about 5 stages of acute inflammation of the middle ear: the stage of acute eustachitis, the stage of acute catarrhal inflammation, the stage of acute purulent inflammation, the postperforative stage and the reparative stage. In Russia, the causative agents of acute otitis media are more often S. aureus, S. epidermidis, Str. pneumoniae and Haemophilus influenzae, somewhat less often Str. pyogenes, Moraxella catarrhalis, Str. viridans, anaerobes. Treatment for acute otitis media primarily involves adequate sanitation of the nose and paranasal sinuses, the establishment of an outflow from the middle ear. According to indications, taking into account the age of the patient and the epidemiological situation, antimicrobial drugs are prescribed. Taking into account Russian data on antibiotic resistance, the drug of first choice for acute otitis media is amoxicillin, and for recurrent or severe disease, amoxicillin with clavulanic acid. When prescribing antibacterial drugs, especially oral ones, it is necessary to remember such side effects of the antibiotic as dyspeptic reactions (bloating, pain, nausea, diarrhea). The likelihood of developing side effects from the digestive tract is influenced by the rate of absorption of the drug and its residual concentration in the intestine. One way to reduce the side effects of antibacterial drugs on the human body is the use of dispersible tablets. In addition, the use of the antibiotic and the form of dispersible tablets eliminates the possibility of dosing errors. Antibacterial therapy is also carried out for moderate and severe forms of sinusitis, as well as for a mild form of recurrent course.
About the Author
O. V. Zaytseva
Federal State Budgetary Institution The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia
Россия
Россия
Olga V. Zaytseva, MD, Head of the Scientific and Clinical Department and Head of the Department of Vestibulology and Otoneurology
30 b. 2, Volokolamskoe shosse, Moscow, 123182
References
1. Boykova N. E., El' kun G. B. The use of the drug «Panklav 625 mg» (amoxicillin / clavulanate) in the treatment of acute and chronic inflammatory diseases of the ENT organs // RMJ. 2007; 7: 625-632.
2. Yegorova O. A. The use of amoxicillin/clavulanate in the treatment of ENT infections // Farmateka. 2008; 11 (165): 53-58.
3. Tarasova G. D. Epidemiology of acute otitis media in children's practice / Mezhdunar. konf. «Antibakter. terapiya v pediatrii». 25-26 maya 1999 g. P. 26-29.
4. University of Michigan Health System. Otitis Media Guideline. April, 2013, 12 p.
5. Teele D. N., Klein J. O., Rosner B., et al. Epidemiology of otitis media during the first seven years of life in children in Greater Boston // J Infect Dis. 1989; 160: 8394.
6. Uhari M., Mantyssaari K., Niemela M. Metaanalitic review of the risk factors for acute otitis media // Clin Infect Dis. 1996; 22: 107983.
7. Pal'chun V. T., Kryukov A. I., Kunel'skaya N. L. i dr. Acute inflammation of the middle ear // Vestnik otorinolaringologii. 1997; 6: 7-11.
8. Ryazantsev S. V., Karneyeva O. V., Garashchenko T. I., Gurov A. V., Kosyakov S. Ya., Polyakov D. P., Nikiforova G. N. Etiopathogenetic therapy of acute otitis media. Clinical guidelines. M., 2014. p. 24.
9. Luchikhin L. A. Acute otitis media // Lechashchiy Vrach. 2003; 8: 35-41.
10. Zagoryanskaya M. Ye., Rumyantseva M. Ye., Kamenetskaya S. B. Tezisy konferentsii Abstracts of the conference «Modern methods of diagnosis and rehabilitation of patients with pathology of the inner ear.» M., 1997. P. 23-24.
11. Pal'chun V. T., Kryukov A. I. s soavt. Acute otitis media // Vestnik otorinolar. 1997; 6: 7-10.
12. Malyavina U. S., Goncharova M. G., Ovchinnikov A. Yu. Antimicrobial therapy of acute purulent otitis media in pediatric practice: the feasibility of using cephalosporins // Consilium Medicum (pediatriya). 2007; 1 (09).
13. Strachunskiy L. S., Belousov Yu. B., Kozlov S. N. A practical guide to antiinfective chemotherapy. // Smolensk: MAKMAKH, 2007. P. 464.
14. Kozlov R. S. Antibiotics for acute otitis media in children: to whom, when, how? // Detskaya otorinolaringologiya. 2011; 1: 20-24.
15. Luchikhin L. A. Lecheniye vospalitel'nykh zabolevaniy srednego ukha // The Lechaschi Vrach Journal. 2004; 8: 6-10.
16. Lyakh G. S., Maruseva A. M. Audiological bases of rehabilitation of children with sensorineural hearing loss. // L.: Meditsina, 1979. P. 234.
17. European Position Paper in Rhinosinusitis and Nasal Polyposis Rhinology Rhinology. 2012; 50 (1): 1-12.
18. Savvateyeva D. M., Lopatin A. S. Diagnosis and treatment of olfactory dysfunction in patients with acute rhinosinusitis // Rossiyskaya rinologiya. 2010; 2: 8-11.
19. Dimov D. A. Violation of smell in diseases of the nasal cavity // Zhurn. ushn., nos. i gorl. bol. 1978; 4: 75-76.
20. Yeshun Wu, et al. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2020.03.031.
21. Hura N., Xie D. X., Choby G. W., et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations // Int Forum Allergy Rhinol. 2020; 10 (9): 1065-1086.
22. Hummel T., Heilmann S., Hüttenbriuk K. B. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract // Laryngoscope. 2002; 112 (11): 2076-2080.
23. Hummel T., Rissom K., Reden J., et al. Effects of olfactory training in patients with olfactory loss // Laryngoscope. 2009; 119 (3): 496-499.
24. Fleiner F., Lau L., Göktas Ö. Active olfactory training for the treatment of smelling disorders // Ear Nose Throat J. 2012; 91 (5): 198-215.
25. Konstantinidis I., Tsakiropoulou E., Bekiaridou P., et al. Use of olfactory training in post?traumatic and postinfectious olfactory dysfunction // Laryngoscope. 2013; 123 (12): 85-90.
26. Damm M., Pikart L. K., Reimann H., et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study // Laryngoscope. 2014; 124 (4): 826-831.
27. Geißler K., Reimann H., Gudziol H., et al. Olfactory training for patients with olfactory loss after upper respiratory tract infections // Eur Arch Oto-Rhino-Laryngology. 2014; 271 (6): 1557-1562.
28. Altundag A., Cayonu M., Kayabasoglu G., et al. Modified olfactory training in patients with postinfectious olfactory loss // Laryngoscope. 2015; 125 (8): 1763-1766.
29. Konstantinidis I., Tsakiropoulou E., Constantinidis J. Long term effects of olfactory training in patients with postinfectious olfactory loss // Rhinology. 2016; 54 (2): 170-175.
30. Poletti S. C., Michel E., Hummel T. Olfactory training using heavy and light weight molecule odors // Perception. 2017; 46 (3-4): 343-351.
31. Nguyen T. P., Patel Z. M. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss // Int Forum Allergy Rhinol. 2018; 8 (9): 977-981.
32. Instructions for the drug Amoxicillin. EKSPRESS LP-005523 ot 20.05.2019.
33. Instructions for the drug Amoxicillin + Clavulanic acid. EKSPRESS LP-005622 ot 01.07.2019.
34. Zyryanov S. K., Baybulatova Ye. A. The use of new dosage forms of antibiotics as a way to improve the effectiveness and safety of antibacterial therapy // Antibiotiki i khimioterapiya. 2019; 64 (3-4): 81-91.
35. WHO. Fact Sheet No. 331 November 2015 (http://www.who.int/mediacentre/factsheets/fs331/en/).
36. Sukhanov D. S., Mar'yushkina V. S., Azovtsev D. Yu. Modern features of the treatment of acute bronchitis. The effect and advantages of the dispersible form of antibacterial drugs // The Lechaschi Vrach Journal. 2022; 25 (3): 70-75.
Review
For citations:
Zaytseva O.V. Otoneurological and neurological consequences of acute infectious ENT diseases. Lechaschi Vrach. 2022;(12):79-84. (In Russ.) https://doi.org/10.51793/OS.2022.25.12.013
Views:
1515
JATS XML
Email this article 
